American Journal of Obstetrics & Gynecology
Volume 194, Issue 5 , Pages 1311-1315 , May 2006

Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality

  • Andra H. James, MD

      Affiliations

    • Divisions of Maternal-Fetal Medicine
    • Corresponding Author InformationReprint requests: Andra H. James, MD, Box 3967 DUMC, Durham, NC 27710.
    • ,
  • Margaret G. Jamison, PhD

      Affiliations

    • Epidemiology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC
    • ,
  • Leo R. Brancazio, MD

      Affiliations

    • Divisions of Maternal-Fetal Medicine
    • ,
  • Evan R. Myers, MD

      Affiliations

    • Epidemiology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC

Received 18 July 2005 ,Revised 10 September 2005 ,Accepted 4 November 2005.

References 

  1. Heit J, Kobbervig C, James A, Petterson T, Bailey KR, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism during pregnancy or the puerperium: a 30-year population-based study. Ann Intern Med. 2005;143:697–706
  2. Maternal mortality in 2000: estimates developed by WHO, UNICEF and UNFPA. WHO; 2004.
  3. Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, et al. Pregnancy-related mortality surveillance—United States, 1991-1999. MMWR Surveill Summ. 2003;52:1–8
  4. Bergqvist A, Bergqvist D, Lindhagen A, Matzsch T. Late symptoms after pregnancy-related deep vein thrombosis. BJOG. 1990;97:338–341
  5. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol. 2002;101:6–14
  6. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol. 2002;99:333–341
  7. Introduction to the Nationwide Inpatient Sample (NIS) 2002. Healthcare Cost and Utilization Project (HCUP), Rockville, MD: Agency for Healthcare Research and Quality; June 2004.
  8. Overview of the Nationwide Inpatient Sample (NIS) 2000. Rockville, MD: Healthcare Cost and Utilization Project (HCUP), Rockville, MD: Agency for Healthcare Research and Quality; May 2002.
  9. Kierkegaard A. Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstet Gynecol Scand. 1983;62:239–243
  10. McColl MD, Ramsay JE, Tait RC, Walker ID, McCall F, Conkie JA, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost. 1997;78:1183–1188
  11. Macklon NS, Greer IA. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott Med J. 1996;41:83–86
  12. Andersen BS, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. The cumulative incidence of venous thromboembolism during pregnancy and puerperium—an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand. 1998;77:170–173
  13. Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG. 2001;108:56–60
  14. Soomro RM, Bucur IJ, Noorani S. Cumulative incidence of venous thromboembolism during pregnancy and puerperium: a hospital-based study. Angiology. 2002;53:429–434
  15. Arnason T, Wells PS, van Walraven C, Forster AJ. Accuracy of coding for possible warfarin complications in hospital discharge abstracts. Thromb Res. 2005;1:1
  16. James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005;193:216–219
  17. Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv. 1999;54:265–271
  18. Franks AL, Atrash HK, Lawson HW, Colberg KS. Obstetrical pulmonary embolism mortality, United States, 1970-85. Am J Public Health. 1990;80:720–722
  19. Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol. 2003;101:289–296
  20. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999;159:445–453
  21. Danilenko-Dixon DR, Heit JA, Silverstein MD, Yawn BP, Petterson TM, Lohse CM, et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol. 2001;184:104–110
  22. Ho J, Sibbald WJ, Chin-Yee IH. Effects of storage on efficacy of red cell transfusion: when is it not safe?. Crit Care Med. 2003;31(Suppl 12):S687–S697
  23. Hauth J. MFMU cesarean registry: thromboembolism-occurrence and risk factors in 39,285 cesarean births. Am J Obstet Gynecol. 2003;189(Suppl 1):S120
  24. Royal College of Obstetricians and Gynaecologists (RCOG) . Report of a working party on prophylaxis against thromboembolism in gynaecology and obstetrics. London: Royal College of Obstetricians and Gynaecologists; 1995;
  25. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259–262
  26. Ventura S, Mosher W, Curtin S, Abma J, Henshaw S. Trends in pregnancy rates for the United States, 1976-97: an update. National Vital Statistics Reports. 2001;49:1–10
  27. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):627S–644S

 This study was funded in part by a grant from the National Institutes of Health (5K12-HD043446-03).

PII: S0002-9378(05)02452-X

doi: 10.1016/j.ajog.2005.11.008

American Journal of Obstetrics & Gynecology
Volume 194, Issue 5 , Pages 1311-1315 , May 2006

Article Tools